MRSA: Antibiotics and biocidal cleaners may spread multidrug resistance
Antibiotic use on people or pets, and use of biocidal cleaning products such as bleach, are associated with multidrug resistance in methicillin-resistant Staphylococcus aureus (MRSA) in the home. This contamination More...
WHO report is ‘major step forward’ in fight against drug-resistant bacteria
A new report by the World Health Organization lays out, for the first time, which antibiotic-resistant bacteria pose the greatest risk to global health and urgently need new effective treatments. How antibiotic More...
Antibiotics misused: CDC says 30 percent of antibiotic prescriptions unnecessary
At least 30 percent of antibiotics prescribed in the United States are unnecessary, according to new data published today in the Journal of the American Medical Association (JAMA) by the Centers for Disease Control More...
Study questions antibiotic use in hospice patients
CORVALLIS, Ore. – New research suggests that use of antibiotics is still prevalent among terminal patients who have chosen hospice care as an end-of-life option, despite little evidence that the medications improve More...
Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee
PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...
Notre Dame researchers discover ‘oxadiazoles’, a new class of antibiotics for MRSA treatment
A new class of antibiotics have been discovered that show promise in treating difficult to treat infections caused by Methicillin Resistant Staphylococcus aureus (MRSA) and other threats to public health. MRSAImage/CDC Researchers More...
FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections
PRESS RELEASE Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...
FDA implementing plan to ensure judicious use of antibiotics in food animals
PRESS RELEASE The U.S. Food and Drug Administration today is implementing a plan to help phase out the use of medically important antimicrobials in food animals for food production purposes, such as to enhance More...
CDC: 23,000 Americans die from antibiotic-resistant infections annually
Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result, according to a new report issued by the Centers for Disease More...
Tetraphase presents study results on two next-generation antibiotic candidates, eravacycline and TP-271
Watertown, Mass. pharmaceutical company, Tetraphase Pharmaceuticals, Inc. announced that it has presented results from studies that demonstrate efficacy of two next-generation antibiotic candidates against community-acquired More...
